348 related articles for article (PubMed ID: 30754655)
1. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N
Cells; 2019 Feb; 8(2):. PubMed ID: 30754655
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
[TBL] [Abstract][Full Text] [Related]
3. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
Windus LC; Glover TT; Avery VM
Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
[TBL] [Abstract][Full Text] [Related]
4. Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures.
Fontana F; Sommariva M; Anselmi M; Bianchi F; Limonta P; Gagliano N
Cells; 2024 Jan; 13(2):. PubMed ID: 38247872
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line.
Deezagi A; Safari N
Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048
[TBL] [Abstract][Full Text] [Related]
8. In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer.
Windus LC; Kiss DL; Glover T; Avery VM
Exp Cell Res; 2012 Nov; 318(19):2507-19. PubMed ID: 22841689
[TBL] [Abstract][Full Text] [Related]
9. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
12. PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.
Lim M; Chuong CM; Roy-Burman P
Horm Cancer; 2011 Oct; 2(5):298-309. PubMed ID: 21948155
[TBL] [Abstract][Full Text] [Related]
13. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
14. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
[TBL] [Abstract][Full Text] [Related]
16. Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML).
Di Biase A; Miles AK; Regad T
Methods Mol Biol; 2018; 1692():129-138. PubMed ID: 28986893
[TBL] [Abstract][Full Text] [Related]
17. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
18. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
[TBL] [Abstract][Full Text] [Related]
20. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
Kolijn K; Verhoef EI; van Leenders GJ
Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]